Skip to content

Cardiology researchers at Stanford Medicine are increasingly turning to CRISPR to understand -- and maybe one day -- treat heart disease.

Cardiology researchers at Stanford Medicine are increasingly turning to CRISPR to understand -- and maybe one day -- treat heart disease.

Stanford researchers are building a heart through tissue engineering techniques in the hopes of better treating congenital heart defects.

Stanford researchers are building a heart through tissue engineering techniques in the hopes of better treating congenital heart defects.

After 10 years of living with a special device that helps the heart pump blood, one pediatric patient is part of an elite group of survivors.

After 10 years of living with a special device that helps the heart pump blood, one pediatric patient is part of an elite group of survivors.

A study confirmed that patients with peripheral artery disease have a higher risk of heart attack, and are more likely to have a rarer type of heart attack.

A study confirmed that patients with peripheral artery disease have a higher risk of heart attack, and are more likely to have a rarer type of heart attack.

Published on

Fifty years after the first adult heart transplant in the U.S., the event featured doctors who've contributed to the development of heart transplantation.

Fifty years after the first adult heart transplant in the U.S., the event featured doctors who've contributed to the development of heart transplantation.

Published on